The emerging role of thioredoxin-1 on ROS and metabolic reprogramming in cisplatin resistant lung cancer

被引：0
|
作者：
Wangpaichitr, Medhi [1 ]
Theodoropoulos, George [1 ]
Wu, Chunjin [1 ]
You, Min [2 ]
Feun, Lynn G. [2 ]
Kuo, Macus T. [3 ]
Lampidis, Theodore J. [2 ]
Sayaraj, Niramol [1 ]
机构：
[1] Miami VA Healthcare Syst, Miami, FL USA
[2] Univ Miami, Miami, FL USA
[3] Texas MD Anderson, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1138
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells
    Wangpaichitr, Medhi
    Sullivan, Elizabeth J.
    Theodoropoulos, George
    Wu, Chunjing
    You, Min
    Feun, Lynn G.
    Lampidis, Theodore J.
    Kuo, Macus T.
    Savaraj, Niramol
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) : 604 - 615
  • [2] Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
    Wangpaichitr, Medhi
    Wu, Chunjing
    Li, Ying Ying
    Nguyen, Dan J. M.
    Kandemir, Hande
    Shah, Sumedh
    Chen, Shumei
    Feun, Lynn G.
    Prince, Jeffrey S.
    Kuo, Macus T.
    Savaraj, Niramol
    ONCOTARGET, 2017, 8 (30) : 49275 - 49292
  • [3] Exploiting ROS and metabolic differences to selectively killing cisplatin resistant lung cancer
    Wangpaichitr, Medhi
    Wu, Chunjing
    Li, Ying Ying
    Shah, Sumedh
    Chen, Shu-Mei
    Dinh, Vy
    Kuo, Macus T.
    Feun, Lynn G.
    Savaraj, Niramol
    CANCER RESEARCH, 2016, 76
  • [4] Downregulation of thioredoxin-1 confers resistance to cisplatin and sensitivity to the ROS generating agent elesclomol
    Wangpaichitr, Medhi
    Wu, Chunjing
    You, Min
    Feun, Lynn G.
    Kuo, Macus T.
    Dinh, Vy
    Savaraj, Niramol
    CANCER RESEARCH, 2011, 71
  • [5] "Metabolic Reprogramming" in Ovarian Cancer Cells Resistant to Cisplatin
    Montopoli, M.
    Bellanda, M.
    Lonardoni, F.
    Ragazzi, E.
    Dorigo, P.
    Froldi, G.
    Mammi, S.
    Caparrotta, L.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 226 - 235
  • [6] ROLE OF THE THIOREDOXIN-1 IN HEART FAILURE
    Medali, Tania
    Couchie, Dominique
    Mougenot, Nathalie
    Rouis, Mustapha
    Friguet., Bertrand
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 189 : 19 - 19
  • [7] Thioredoxin-1 in cancer development and treatment
    Powis, G
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S9 - S9
  • [8] Reactions of Cisplatin with Thioredoxin-1 Regulate Intracellular Redox Homeostasis
    Wang, Shenghu
    Yuan, Siming
    Hu, Hongze
    Zhang, Jiahai
    Cao, Kaiming
    Wang, Yu
    Liu, Yangzhong
    INORGANIC CHEMISTRY, 2024, 63 (25) : 11779 - 11787
  • [9] The essential role of thioredoxin-1 in osteogenic differentiation
    Mendoza, Brenda
    Jewell, Megan
    Cowley, Caroline
    Hansen, Jason
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 224
  • [10] The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation
    Muri, Jonathan
    Heer, Sebastian
    Matsushita, Mai
    Pohlmeier, Lea
    Tortola, Luigi
    Fuhrer, Tobias
    Conrad, Marcus
    Zamboni, Nicola
    Kisielow, Jan
    Kopf, Manfred
    NATURE COMMUNICATIONS, 2018, 9
12345